HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Transformers" spotted

This article was originally published in The Rose Sheet

Executive Summary

Skin- and hair-care formulas that change from one state to another - and those with claims that migrate from one category to another - are on the rise, according to reps from market research firm Mintel at the in-cosmetics conference in Paris. Nica Lewis, Mintel's director of beauty innovation, cited Chinese brand HerbaCeutic's Ultra Hydrating Mousse Mask as a "transformer" because of its mousse texture, which is most commonly encountered in hair and shaving products, rather than skin care. Oriks Magic B.B. Cream from Japanese firm Pars is another example, she says, as it works as a concealer, foundation and sunscreen and uses "chameleon technology," changing color to match user skin tone, similar to a tinted moisturizer. Lewis also points to U.S.-based Kairos' Acne Care Solutions - a line of hair-care products that makes skin-care claims - noting: Kairos "has made the connection that some hair products actually worsen acne and skin irritation" and created a scalp product that helps control skin breakouts

You may also be interested in...



Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel